REQUEST A DEMO
Total
USD $0.00
Search more companies

Rede-Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Rede-Pharma Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Rede-Pharma Kft. is based in Hungary. The head office is in Gyongyos. The company operates in the Pharmacies and Drug Stores industry. The company was established on January 30, 2018. 1 (2024) employees currently work for Rede-Pharma Kft.. From the latest financial highlights, Rede-Pharma Kft. reported a net sales revenue increase of 12.5% in 2023. There was a total negative growth of 25.46% in Rede-Pharma Kft.’s total assets over the same period. In 2023, Rede-Pharma Kft.’s net profit margin increased by 3.93%.

Headquarters
Deak Ferenc utca 44.
Gyongyos; Heves; Postal Code: 3200

Contact Details: Purchase the Rede-Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Rede-Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Rede-Pharma Kft. report to view the information.
Registered Capital:
Purchase the Rede-Pharma Kft. report to view the information.
Incorporation Date:
January 30, 2018
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Rede-Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
12.5%
Total operating revenue
12.31%
Operating profit (EBIT)
85.24%
EBITDA
84.27%
Net Profit (Loss) for the Period
87.56%
Total assets
-25.46%
Total equity
-57.93%
Operating Profit Margin (ROS)
4.21%
Net Profit Margin
3.93%
Return on Equity (ROE)
68.45%
Quick Ratio
-5.49%
Cash Ratio
-0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?